Search results for: 'formulation components sign'
- Did you mean
- formulation components size
- formulation components skin
- Related search terms
- Significant Sludge Treatment and Disposal Opportunities in China
- sign graphics
- sign protection products in us
- sign purification market
- sign building market
-
08 Oct 2025  |  Global  |  Market Research
Global Vital Signs Monitoring Market, Forecast to 2030
Vital Signs Monitoring Is Experiencing Transformational Growth Due to Development of Wearables
Vital signs monitoring devices that support remote monitoring are growing rapidly due to the increasing need for home care and chronic disease management solutions. Moreover, the increasing workload on clinicians and nurses is driving demand for continuous vital signs monitoring solutions in hospital settings. Clinical-grade wearables are dominatin...
$4,950.00 -
19 Feb 2024  |  Global  |  Market Research
Innovations in Small Molecule Drug Delivery and Formulation
Disruptive Technologies Drive Growth Opportunities for New Product Launches
Small molecules, which are the leading drug class across indications, face several issues that threaten their drug delivery efficacy. They suffer from off-target effects, poor bioavailability, low solubility, systemic toxicity, and poor permeability. While the small molecule drug development pipeline remains a leading therapeutic class, it is essen...
$4,950.00
Special Price $3,712.50 save 25 %
-
18 May 2026  |  Global  |  Frost Radar
Frost Radar™: Smart Delivery Formulations for Biologics, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
Biologics, particularly peptide and protein therapies, are a rapidly growing therapeutic area because they can target complex biological pathways with high efficacy. These therapies are becoming important in oncology, metabolic disease, and autoimmune conditions supported by the growing global disease burden and growth in areas such as GLP-1s and m...
$4,950.00 -
23 Jun 2021  |  Global  |  Technology Research
Global RNA Therapeutics:Technology Growth Opportunities
Advances in RNA Modifications, Formulation, and Stabilization to Drive Growth of RNA Therapeutics
RNA therapeutics is a rapidly expanding area of next-generation biological drugs. RNA is a versatile molecule and naturally regulates gene expression, either by upregulation or downregulation. This function is employed to design novel RNA therapeutics. The fundamentals of RNA therapeutics consists of delivering functional RNA at a target; however, ...
$4,950.00
Special Price $3,712.50 save 25 %
-
27 Apr 2023  |  Global  |  Technology Research
Technology Innovations and Growth Opportunities in Inhaled Therapeutics
Nanoparticle-based Formulation to Drive Transformational Growth Across Inhaled Vaccines and Monoclonal Antibodies
Inhalation drug delivery involves administering drugs to the lungs through the mouth (pulmonary route) or nose (intranasal route), enabling them to bypass the blood-brain barrier. Small molecules have been the main focus for inhalation delivery, but recent R&D and increased interest in inhalable COVID-19 vaccines have led to a shift toward inhalabl...
$4,950.00
Special Price $3,712.50 save 25 %
-
28 Jun 2023  |  Global  |  Technology Research
Microbiome Technologies for Nutraceuticals and Personal Care: Technology and Application Analysis
Postbiotics, Psychobiotics, and Topical Probiotics to Drive Growth Strategies in Nutraceuticals and Personal Care Formulations
The human microbiome is made of several microorganisms that reside within and outside the body. These comprise complex and diverse bacteria, archaea, fungi, viruses, and protozoa. They form signature colonies unique to an individual or body part and help maintain general health and wellness. Any disruptions to the naturally occurring healthy microb...
$4,950.00
Special Price $3,712.50 save 25 %
-
15 Jul 2024  |  Global  |  Technology Research
Connected Diabetes Care: Innovations and Growth Opportunities
Continuous Glucose Monitoring, Artificial Pancreas Systems, and Novel Insulin Delivery Formulations to Transform the Future of Diabetes Management
The preference for diabetes self-assessment using wearable CGMs instead of finger-stick blood sugar testing is increasing, especially in type 1 diabetics (T1D). HbA1c and time-in-range are currently the preferred biomarkers for diabetes monitoring applications. Emerging diet and fitness tracking apps help support general well-being and prevent the ...
$4,950.00
Special Price $3,712.50 save 25 %
-
22 Aug 2025  |  Global  |  Technology Research
Second Skin Diagnostics: Innovations and Growth Opportunities, 2025–2029
Wearable diagnostic patches are revolutionizing non-invasive health monitoring, enabling real-time detection of biomarkers for personalized care
Second skin diagnostics refers to the emerging class of ultra-thin, flexible biosensors designed to adhere seamlessly to the skin and continuously monitor a range of physiological signals in real time. Made from stretchable, skin-like materials, these wearables can track vital signs and biomarkers, such as temperature, hydration, glucose, and heart...
$4,950.00 -
21 Sep 2026  |  Global  |  Frost Radar
Frost Radar: Smart Nutraceuticals for Brain Health, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
This Frost Radar evaluates the evolving smart nutraceuticals landscape as consumer awareness of cognitive health, lifestyle-related stress, and healthy aging creates demand for scientifically validated, natural, and multifunctional brain health solutions. The market remains fragmented, with differentiation increasingly shaped by clinical evidence, ...
$4,950.00 -
22 Feb 2013  |  Global  |  Market Research
Overview of the Global Systemic Lupus Erythematosus Pipeline and the Next Three Potential Product Launches
This issue of Vital Signs discusses the change in 2015 Mammogram Guidelines, NeoGenomics' acquistion of Clarient from GE, and Tute Genomics' acquisition of Knome.
$1,500.00
Special Price $1,125.00 save 25 %